Russia says it will no longer abide by self-imposed missile moratorium
In a statement on Monday, the Russian Foreign Ministry linked the decision to efforts by the US and its allies to develop intermediate-range weapons and preparations for their deployment in Europe and other parts of the world.
It specifically cited US plans to deploy Typhoon and Dark Eagle missiles in Germany starting next year.
The ministry noted that such actions by the US and its allies create 'destabilising missile potentials' near Russia, creating a 'direct threat to the security of our country' and carry 'significant harmful consequences for regional and global stability, including a dangerous escalation of tensions between nuclear powers'.
It did not say what specific moves the Kremlin might take, but President Vladimir Putin has previously announced that Moscow was planning to deploy its new Oreshnik missiles on the territory of its neighbour and ally Belarus later this year.
Asked where and when Russia could potentially deploy intermediate-range weapons, Kremlin spokesman Dmitry Peskov said that it is not something to be announced in advance.
'Russia no longer has any limitations, Russia no longer considers itself to be constrained by anything,' Mr Peskov told reporters. 'Therefore, Russia believes it has the right to take respective steps if necessary.'
The Foreign Ministry said: 'Decisions on specific parameters of response measures will be made by the leadership of the Russian Federation based on an interdepartmental analysis of the scale of deployment of American and other Western land-based intermediate-range missiles, as well as the development of the overall situation in the area of international security and strategic stability.'
The Russian statement follows US President Donald Trump's announcement on Friday that he is ordering the repositioning of two US nuclear submarines 'based on the highly provocative statements' of Dmitry Medvedev, who was president in 2008-12 to allow Mr Putin, bound by term limits, to later return to the office.
Mr Trump's statement came as his deadline for the Kremlin to reach a peace deal in Ukraine approaches later this week.
Mr Trump said he was alarmed by Mr Medvedev's attitude. Mr Medvedev, who serves as deputy chairman of Russia's Security Council chaired by Mr Putin, has apparently sought to curry favour with his mentor by making provocative statements and frequently lobbing nuclear threats.
Last week he responded to Mr Trump's deadline for Russia to accept a peace deal in Ukraine or face sanctions by warning him against 'playing the ultimatum game with Russia' and declaring that 'each new ultimatum is a threat and a step toward war'.
Mr Medvedev also commented on the Foreign Ministry's statement, describing Moscow's withdrawal from the moratorium as 'the result of Nato countries' anti-Russian policy'.
'This is a new reality all our opponents will have to reckon with,' he wrote on X. 'Expect further steps.'
Intermediate-range missiles can fly between 500 to 5,500 kilometres (310 to 3,400 miles). Such land-based weapons were banned under the 1987 Intermediate-range Nuclear Forces (INF) Treaty.
Washington and Moscow abandoned the pact in 2019, accusing each other of violations, but Moscow declared its self-imposed moratorium on their deployment until the US makes such a move.
The collapse of the INF Treaty has stoked fears of a replay of a Cold War-era European missile crisis, when the US and the Soviet Union both deployed intermediate-range missiles on the continent in the 1980s.
Such weapons are seen as particularly destabilising because they take less time to reach targets, compared with intercontinental ballistic missiles, leaving no time for decision-makers and raising the likelihood of a global nuclear conflict over a false launch warning.
Russia's missile forces chief has declared that the new Oreshnik intermediate-range missile, which Russia first used against Ukraine in November, has a range to reach all of Europe. Oreshnik can carry conventional or nuclear warheads.
Mr Putin has praised the Oreshnik's capabilities, saying its multiple warheads that plunge to a target at speeds up to Mach 10 are immune to being intercepted and are so powerful that the use of several of them in one conventional strike could be as devastating as a nuclear attack.
Mr Putin has warned the West that Moscow could use it against Ukraine's Nato allies who allowed Kyiv to use their longer-range missiles to strike inside Russia.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South Wales Argus
2 minutes ago
- South Wales Argus
'Trump will never get his Nobel Prize'
Israeli Prime Minister Benjamin Netanyahu has defended allowing the transfer of millions of dollars to Hamas-run Gaza despite criticism from within his own government, including the education minister Naftali Bennet. For years, the various governments led by Benjamin Netanyahu took an approach that divided power between the Gaza Strip and the West Bank — bringing Palestinian Authority President Mahmoud Abbas to his knees while making moves that propped up the Hamas terror group. Donald Trump has said his administration is now exploring the possibility of normalising relations with Syria - his comments coming shortly after he met Syria's interim President Ahmed al-Sharaa. The extraordinary encounter, unthinkable just months ago, was short but significant. "I think he has got the potential," Trump remarked after his meeting in Riyadh, 37 minutes long, with the former Syrian fighter, formerly linked to al-Qaeda, the same group that attacked the twin towers. The $10m US bounty on his head was only lifted in December. Or is it just another outlet to moan about Starmer? If Palestine becomes a safe place to live and work, many millions will return. Trump will never get his Nobel Prize, and both he and Israel will be on the wrong end of history. Andrew Nutt Bargoed
The Independent
32 minutes ago
- The Independent
Harvard scientists say research could be set back years after funding freeze
Harvard University professor Alberto Ascherio's research is literally frozen. Collected from millions of U.S. soldiers over two decades using millions of dollars from taxpayers, the epidemiology and nutrition scientist has blood samples stored in liquid nitrogen freezers within the university's T.H. Chan School of Public Health. The samples are key to his award-winning research, which seeks a cure to multiple sclerosis and other neurodegenerative diseases. But for months, Ascherio has been unable to work with the samples because he lost $7 million in federal research funding, a casualty of Harvard's fight with the Trump administration. 'It's like we have been creating a state-of-the-art telescope to explore the universe, and now we don't have money to launch it,' said Ascherio. 'We built everything and now we are ready to use it to make a new discovery that could impact millions of people in the world and then, 'Poof. You're being cut off.'' Researchers laid off and science shelved The loss of an estimated $2.6 billion in federal funding at Harvard has meant that some of the world's most prominent researchers are laying off young researchers. They are shelving years or even decades of research, into everything from opioid addiction to cancer. And despite Harvard's lawsuits against the administration, and settlement talks between the warring parties, researchers are confronting the fact that some of their work may never resume. The funding cuts are part of a monthslong battle that the Trump administration has waged against some the country's top universities including Columbia, Brown and Northwestern. The administration has taken a particularly aggressive stance against Harvard, freezing funding after the country's oldest university rejected a series of government demands issued by a federal antisemitism task force. The government had demanded sweeping changes at Harvard related to campus protests, academics and admissions — meant to address government accusations that the university had become a hotbed of liberalism and tolerated anti-Jewish harassment. Research jeopardized, even if court case prevails Harvard responded by filing a federal lawsuit, accusing the Trump administration of waging a retaliation campaign against the university. In the lawsuit, it laid out reforms it had taken to address antisemitism but also vowed not to 'surrender its independence or relinquish its constitutional rights.' 'Make no mistake: Harvard rejects antisemitism and discrimination in all of its forms and is actively making structural reforms to eradicate antisemitism on campus," the university said in its legal complaint. 'But rather than engage with Harvard regarding those ongoing efforts, the Government announced a sweeping freeze of funding for medical, scientific, technological, and other research that has nothing at all to do with antisemitism.' The Trump administration denies the cuts were made in retaliation, saying the grants were under review even before the demands were sent in April. It argues the government has wide discretion to cancel federal contracts for policy reasons. The funding cuts have left Harvard's research community in a state of shock, feeling as if they are being unfairly targeted in a fight has nothing to do with them. Some have been forced to shutter labs or scramble to find non-government funding to replace lost money. In May, Harvard announced that it would put up at least $250 million of its own money to continue research efforts, but university President Alan Garber warned of 'difficult decisions and sacrifices' ahead. Ascherio said the university was able to pull together funding to pay his researchers' salaries until next June. But he's still been left without resources needed to fund critical research tasks, like lab work. Even a year's delay can put his research back five years, he said. Knowledge lost in funding freeze 'It's really devastating,' agreed Rita Hamad, the director of the Social Policies for Health Equity Research Center at Harvard, who had three multiyear grants totaling $10 million canceled by the Trump administration. The grants funded research into the impact of school segregation on heart health, how pandemic-era policies in over 250 counties affected mental health, and the role of neighborhood factors in dementia. At the School of Public Health, where Hamad is based, 190 grants have been terminated, affecting roughly 130 scientists. 'Just thinking about all the knowledge that's not going to be gained or that is going to be actively lost," Hamad said. She expects significant layoffs on her team if the funding freeze continues for a few more months. "It's all just a mixture of frustration and anger and sadness all the time, every day." John Quackenbush, a professor of computational biology and bioinformatics at the School of Public Health, has spent the past few months enduring cuts on multiple fronts. In April, a multimillion dollar grant was not renewed, jeopardizing a study into the role sex plays in disease. In May, he lost about $1.2 million in federal funding for in the coming year due to the Harvard freeze. Four departmental grants worth $24 million that funded training of doctoral students also were cancelled as part of the fight with the Trump administration, Quackenbush said. 'I'm in a position where I have to really think about, 'Can I revive this research?'' he said. 'Can I restart these programs even if Harvard and the Trump administration reached some kind of settlement? If they do reach a settlement, how quickly can the funding be turned back on? Can it be turned back on?' The researchers all agreed that the funding cuts have little or nothing to do with the university's fight against antisemitism. Some, however, argue changes at Harvard were long overdue and pressure from the Trump administration was necessary. Bertha Madras, a Harvard psychobiologist who lost funding to create a free, parent-focused training to prevent teen opioid overdose and drug use, said she's happy to see the culling of what she called 'politically motivated social science studies.' White House pressure a good thing? Madras said pressure from the White House has catalyzed much-needed reform at the university, where several programs of study have 'really gone off the wall in terms of being shaped by orthodoxy that is not representative of the country as a whole.' But Madras, who served on the President's Commission on Opioids during Trump's first term, said holding scientists' research funding hostage as a bargaining chip doesn't make sense. 'I don't know if reform would have happened without the president of the United States pointing the bony finger at Harvard," she said. 'But sacrificing science is problematic, and it's very worrisome because it is one of the major pillars of strength of the country.' Quackenbush and other Harvard researchers argue the cuts are part of a larger attack on science by the Trump administration that puts the country's reputation as the global research leader at risk. Support for students and post-doctoral fellows has been slashed, visas for foreign scholars threatened, and new guidelines and funding cuts at the NIH will make it much more difficult to get federal funding in the future, they said. It also will be difficult to replace federal funding with money from the private sector. 'We're all sort of moving toward this future in which this 80-year partnership between the government and the universities is going to be jeopardized,' Quackenbush said. 'We're going to face real challenges in continuing to lead the world in scientific excellence.'
North Wales Chronicle
3 hours ago
- North Wales Chronicle
Trump could meet Putin as soon as next week, White House official says
The official cautioned that a meeting has not been scheduled yet and no location has been determined. The official was not authorised to speak publicly and spoke to The Associated Press on condition of anonymity to discuss internal plans. The White House said Mr Trump was also open to a meeting with both Mr Putin and Ukrainian President Volodymyr Zelensky. A meeting between Mr Putin and Mr Trump would be their first since Mr Trump returned to office this year. It would be a significant milestone in the three-year-old war, though there is no promise such a meeting would lead to the end of the fighting since Russia and Ukraine remain far apart on their demands. News of a potential meeting with Mr Putin, which was first reported by The New York Times, came hours after Mr Trump's special envoy Steve Witkoff met Mr Putin in Moscow. Mr Trump had posted earlier on Truth Social that Mr Witkoff 'had a highly productive meeting' with Mr Putin in which 'great progress was made'. It was not immediately clear if Mr Putin or Mr Zelensky had agreed to any meetings with Mr Trump. Mr Zelensky has been willing to meet face-to-face with Mr Putin to end the conflict, but Russia has repeatedly rejected the idea. Mr Trump has met Mr Zelensky several times this year, including a contentious February meeting in Washington. Though he has not yet met Mr Putin this year, Mr Trump met with him five times during his first term. Mr Trump said earlier on Wednesday that he updated America's allies in Europe and that they will work toward an end to the Russia-Ukraine war 'in the days and weeks to come'. White House press secretary Karoline Leavitt said: 'The Russians expressed their desire to meet with President Trump, and the President is open to meeting with both President Putin and President Zelensky.' Her statement did not address the potential timing of any meeting. Mr Witkoff met Mr Putin days before the White House's deadline for Russia to reach a peace deal with Ukraine or potentially face severe economic penalties that could also hit countries buying its oil. The meeting between Mr Putin and Mr Witkoff lasted about three hours, the Kremlin said. Mr Putin's foreign affairs adviser Yuri Ushakov said Mr Putin and Mr Witkoff had a 'useful and constructive conversation' that focused on the Ukrainian crisis and, in a nod toward improving relations between Washington and Moscow, 'prospects for possible development of strategic co-operation' between the United States and Russia.
